Abaloparatide
Indication
Treating osteoporosis after menopause (NICE TA991)
NICE TA991 - Abaloparatide for treating osteoporosis after menopause
Red
Brand:
Nice TA:
991
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Endocrine system